Loading clinical trials...

The Implementation and Impact of an Allergy De-Labeling Program in the Emergency Department | Clinical Trials | Clareo Health

Back to clinical trial search

Enrolling By InvitationPhase 1NCT06823154

The Implementation and Impact of an Allergy De-Labeling Program in the Emergency Department

Beta-lactams are the most common antibiotics prescribed to children, including penicillin and amoxicillin. They are usually more effective and have fewer side effects than other ty antibiotics. Some c...

Lead sponsor: The Hospital for Sick Children•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Trial snapshot

StatusENROLLING_BY_INVITATION

PhasePHASE1

Enrollment500

Start dateNov 2023

Last updatedNov 26, 2025

Condition

Allergy Amoxicillin Beta-lactam Allergy Labels

Locations shown

Monica Caldeira-Kulbakas

Toronto, Ontario

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 26, 2025Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions